Literature DB >> 18485713

Zolpidem improves akinesia, dystonia and dyskinesia in advanced Parkinson's disease.

Yen-Yu Chen, Hiu-Ngar Sy, Shey-Lin Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18485713     DOI： 10.1016/j.jocn.2007.07.082

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


× No keyword cloud information.
  9 in total

1.  High-dose zolpidem withdrawal seizure in a patient with spinocerebellar ataxia.

Authors:  Cheng-Chen Chang; Wen-Fang Wang
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

Review 3.  Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases.

Authors:  Thomas J Feuerstein; Miriam Kammerer; Carl Hermann Lücking; Andreas Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

4.  Treatment of Isolated Dystonia with Zolpidem.

Authors:  Yoshimichi Miyazaki; Hidetaka Koizumi; Ryosuke Miyamoto; Toshitaka Kawarai; Ryuji Kaji
Journal:  Mov Disord Clin Pract       Date:  2015-12-18

Review 5.  X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.

Authors:  Raymond L Rosales
Journal:  J Mov Disord       Date:  2010-10-30

6.  GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson's disease.

Authors:  S D Hall; E J Prokic; C J McAllister; K C Ronnqvist; A C Williams; N Yamawaki; C Witton; G L Woodhall; I M Stanford
Journal:  Neuroscience       Date:  2014-09-28       Impact factor: 3.590

7.  Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study.

Authors:  Shiro Horisawa; Kotaro Kohara; Hiroki Ebise; Masahiko Nishitani; Takakazu Kawamata; Takaomi Taira
Journal:  Front Neurol       Date:  2022-05-03       Impact factor: 4.003

Review 8.  Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.

Authors:  Antonio Daniele; Francesco Panza; Antonio Greco; Giancarlo Logroscino; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-05-17

9.  Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface.

Authors:  Ahmad Tarmizi Che Has; Nathan Absalom; Petra S van Nieuwenhuijzen; Andrew N Clarkson; Philip K Ahring; Mary Chebib
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.